Masimo CEO: Our healthcare investors don't know how to deal with the consumer side of the business
Joe Kiani, Masimo CEO, joins 'Closing Bell Overtime' to talk the proxy fight, its healthcare versus its consumer segment,ย ...
Executive Vice President & Chief Financial Officer, Masimo
Search every verified Micah Young interview, podcast appearance, and on-the-record quote โ each transcript cross-checked by AI and human review to confirm speaker identity. Micah Young, Executive Vice President and Chief Financial Officer at Masimo, accompanied CEO Joe Kiani on a listening tour of major shareholders that led to discussions about spinning off the company's consumer health business. Kiani stated that the tour revealed a disconnect: healthcare investors were unfamiliar with the consumer side of the business, and the company sought a way to separate that segment without abandoning its broader goals for patients, people, and shareholders. Kiani also discussed the upcoming launch of a hospital-grade baby monitor with pulse oximetry, priced at approximately $200 without a camera and $300 with a camera featuring edge AI to detect if a baby has rolled face down. He described the product as the first hospital-grade pulse oximeter available for home use and said it should be significant for Masimo's stockholders. Kiani explained that Masimo's strategy involves both selling its own end-user products and working with OEMs, a "push/pull" approach he said has worked in healthcare.
“We began talking about doing a spin-off after my CFO and I went on a listening tour meeting our major shareholders, and what we realized short term we're going to be right. Long term I was going to be right that the best thing is to keep it all together but short term we're a health care company, and our health care in...”
“The time, we decided there might be a way to separate the consumer health without giving up the dream of what we're hoping to accomplish, for patients, people and our shareholders effectively.”
“We're offering the boot monitor without the camera and this is the camera that has its own cool edge A.I. built into it to tell you if the baby has rolled down face down or other issues in the future but the monitor itself for pulse oximetry drop is going to be about $200. With the camera you're talking about $300. It...”
“There has never been a hospital grade, let alone Masimo which we are the most reliable pulse oximeter on the planet, been available for parents at home, so yeah, it should be big. It should change things and it should be great for Masimo's stockholders.”
Joe Kiani, Masimo CEO, joins 'Closing Bell Overtime' to talk the proxy fight, its healthcare versus its consumer segment,ย ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Micah Young.